Brief: Eurobio Scientific And NG Biotech Enter Into Marketing Agreement For COVID-19 Serology Rapid Tests
05/05/2020 17:38
May 5 (Reuters) - EUROBIO SCIENTIFIC SA ALERS.PA :
* SIGNS COMMERCIALIZATION AGREEMENT WITH NG BIOTECH ON
SEROLOGICAL
TESTS FOR COVID 19
* TEST IS DEVELOPED, MANUFACTURED AND CLINICALLY VALIDATED
IN
FRANCE BY THE COMPANY NG BIOTECH
Source text for Eikon: ID:nGNE7JYzJV
Further company coverage: ALERS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Eurobio Scientific SA
See all newsBrief: Eurobio Scientific EB Development Files Public Offer For Shares
Brief: Eurobio Scientific Says At End Of June 2024, Recorded Revenues Of 73.4 Mln Euros, Compared With 59.1 Mln Euros A Year Ago
Brief: Eurobio Scientific FY Core Business Revenues Up At EUR 130 Mln
Brief: Eurobio Scientific Cancels 694,300 Treasury Shares, Representing Around 6.34% Of Share Capital
Brief: Eurobio Scientific H1 Ebitda Up To EUR 13.4 Million